The Venture Codex Logo

The Venture Codex

Overview

Biotech company developing novel antibody treatments for I&I disorders.

Total Raised

$272 M

Rounds

3

Links

Verticals

Biotechnology
Health Care
Medical
Therapeutics

Investment History

  1. Series C

    Jun 2026

    $65M

  2. Series B

    Oct 2024

    $115M

  3. Series A

    Oct 2023

    $92M

Team

Tillman Gerngross

Founder

Leonard Zon

Founder

Bhaskar Srivastava

Chief Medical Officer

Elizabeth Mateer

Principal Scientist, Biomarkers